• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲型 H1N1 流感大流行感染的肾移植受者的发病率和死亡率:与非免疫功能低下患者的对比分析。

Morbimortality of pandemic influenza A H1N1 infection in kidney transplant recipients requiring hospitalization: a comparative analysis with nonimmunocompromised patients.

机构信息

Division of Infectious Diseases, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

出版信息

Transplantation. 2012 Jan 15;93(1):69-72. doi: 10.1097/TP.0b013e31823aa528.

DOI:10.1097/TP.0b013e31823aa528
PMID:22203390
Abstract

BACKGROUND

Clinical and epidemiological data of pandemic influenza A H1N1 infection in solid-organ transplant recipients have been described, but scarce data compare these outcomes with nonimmunocompromised patients.

METHODS

We retrospectively reviewed and compared the clinical presentation, morbidity, and mortality of all kidney transplant (KT) and nonimmunocompromised (non-KT) patients admitted for at least 12 hr with a diagnosis of pandemic influenza A H1N1 infection in a single hospital complex during the 2009 pandemic.

RESULTS

There were 22 patients in the KT group (29.3%) and 53 in the non-KT group (70.7%). The prevalence of diabetes was higher in KT group (27.3% vs. 5.7%) while chronic pulmonary disease was more frequent in non-KT group (34% vs. 9.1%). Clinical and radiological presentations and duration of disease were similar between the two groups. The incidence of acute renal failure was higher among KT patients (40.9% vs. 17%). No differences in the rate of intensive care unit admission (22.7% vs. 22.6%) or hospital mortality (9.1% vs. 7.5%) were observed. For the overall population, poor outcome, defined as intensive care unit admission or death, was associated with in-hospital acquisition (relative risk [RR]=42.6 [95% confidence interval {95% CI } 2.2-831.9], P=0.003), symptom onset more than 48 hr (RR=12.17 [95% CI 1.3-117.2], P=0.007), and acute renal failure (RR=11.8 [95% CI 2.9-48.8], P<0.001). Among KT recipients, in-hospital acquisition was the only covariate associate with poor outcome (RR=30.0 [95% CI 2.1-421.1], P=0.004).

CONCLUSIONS

No significant differences in morbidity and mortality were observed comparing KT and non-KT patients infected with pandemic H1N1 influenza A virus.

摘要

背景

已描述了大流行性甲型 H1N1 流感感染在实体器官移植受者中的临床和流行病学数据,但很少有数据将这些结果与非免疫功能低下患者进行比较。

方法

我们回顾性地比较和比较了在 2009 年大流行期间,在一个单一医院中至少住院 12 小时并诊断为大流行性甲型 H1N1 流感感染的所有肾移植(KT)和非免疫功能低下(非-KT)患者的临床表现、发病率和死亡率。

结果

在 KT 组中有 22 例(29.3%)和 53 例非-KT 组(70.7%)。在 KT 组中,糖尿病的患病率较高(27.3%对 5.7%),而慢性肺部疾病在非-KT 组中更为常见(34%对 9.1%)。两组之间的临床和影像学表现以及疾病持续时间相似。急性肾衰竭的发生率在 KT 患者中较高(40.9%对 17%)。入住重症监护病房的比率(22.7%对 22.6%)或医院死亡率(9.1%对 7.5%)无差异。对于整个人群,定义为入住重症监护病房或死亡的不良预后与院内获得性感染有关(相对风险[RR]为 42.6 [95%置信区间{95%CI}为 2.2-831.9],P=0.003),症状发作超过 48 小时(RR=12.17 [95%CI 1.3-117.2],P=0.007)和急性肾衰竭(RR=11.8 [95%CI 2.9-48.8],P<0.001)。在 KT 受者中,院内获得性感染是唯一与不良预后相关的混杂因素(RR=30.0 [95%CI 2.1-421.1],P=0.004)。

结论

在感染大流行性甲型 H1N1 流感病毒的 KT 和非-KT 患者中,发病率和死亡率无显着差异。

相似文献

1
Morbimortality of pandemic influenza A H1N1 infection in kidney transplant recipients requiring hospitalization: a comparative analysis with nonimmunocompromised patients.甲型 H1N1 流感大流行感染的肾移植受者的发病率和死亡率:与非免疫功能低下患者的对比分析。
Transplantation. 2012 Jan 15;93(1):69-72. doi: 10.1097/TP.0b013e31823aa528.
2
Comparison of hospitalized solid organ transplant recipients and nonimmunocompromised patients with pandemic H1N1 infection: a retrospective cohort study.住院实体器官移植受者与非免疫抑制的大流行 H1N1 感染患者的比较:一项回顾性队列研究。
Transplantation. 2011 Jul 27;92(2):230-4. doi: 10.1097/TP.0b013e3182200e5c.
3
Critically ill children with pandemic influenza (H1N1) in pediatric intensive care units in Turkey.土耳其儿科重症监护病房中患有大流行性流感(H1N1)的危重病儿童。
Pediatr Crit Care Med. 2012 Jan;13(1):e11-7. doi: 10.1097/PCC.0b013e31820aba37.
4
2009 pandemic influenza A (H1N1) in critically ill children in Cincinnati, Ohio.2009 年俄亥俄州辛辛那提市危重症儿童中的甲型流感 A(H1N1)疫情。
Pediatr Crit Care Med. 2012 May;13(3):e140-4. doi: 10.1097/PCC.0b013e318228845f.
5
Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer.儿童癌症患者中 2009 年大流行 H1N1 流感与季节性流感的特征和结局。
Pediatr Infect Dis J. 2012 Apr;31(4):373-8. doi: 10.1097/INF.0b013e3182481ef8.
6
Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza?大流行 2009 年甲型 H1N1 流感病毒感染住院成人的并发症和结局:它们与季节性流感有何不同?
J Infect Dis. 2011 Jun 15;203(12):1739-47. doi: 10.1093/infdis/jir187.
7
Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences.造血干细胞移植受者中的新型 H1N1 流感:两个中心的经验。
Biol Blood Marrow Transplant. 2011 Apr;17(4):566-73. doi: 10.1016/j.bbmt.2010.07.018. Epub 2010 Aug 11.
8
A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes.一项针对 3 个国家实体瘤患者中甲型 H1N1 流感大流行感染的多中心研究:早期治疗可改善结局。
Cancer. 2012 Sep 15;118(18):4627-33. doi: 10.1002/cncr.27447. Epub 2012 Feb 22.
9
Novel influenza (H1N1) infection in pediatric renal transplant recipients: a single center experience.小儿肾移植受者的新型甲型H1N1流感感染:单中心经验
Pediatr Transplant. 2012 Mar;16(2):123-30. doi: 10.1111/j.1399-3046.2011.01540.x. Epub 2011 Sep 16.
10
Burden of severe 2009 pandemic influenza A (H1N1) infection in children in Southeast Spain.西班牙东南部儿童感染 2009 年大流行严重流感 A(H1N1)的负担。
Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):497-501. doi: 10.1016/j.eimc.2011.01.015. Epub 2011 Apr 21.

引用本文的文献

1
Effect of COVID-19 on Kidney Graft Function One Year after Onset.COVID-19 对发病一年后肾移植功能的影响。
Medicina (Kaunas). 2023 Dec 23;60(1):26. doi: 10.3390/medicina60010026.
2
Vaccination With Live Attenuated Vaccines in Four Children With Chronic Myeloid Leukemia While on Imatinib Treatment.四例慢性髓性白血病儿童在伊马替尼治疗期间接种活减毒疫苗。
Front Immunol. 2020 Apr 17;11:628. doi: 10.3389/fimmu.2020.00628. eCollection 2020.
3
Human Influenza Virus Infections.人类流感病毒感染
Semin Respir Crit Care Med. 2016 Aug;37(4):487-500. doi: 10.1055/s-0036-1584801. Epub 2016 Aug 3.
4
Clinical aspects of influenza A(H1N1)pdm09 cases reported during the pandemic in Brazil, 2009-2010.2009 - 2010年巴西大流行期间报告的甲型H1N1流感病例的临床特征
Einstein (Sao Paulo). 2015 Apr-Jun;13(2):177-82. doi: 10.1590/S1679-45082015AO3331.
5
Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.肾移植患者中流感 H1N1 特异性体液和细胞免疫应答的差异动力学。
Med Microbiol Immunol. 2014 Feb;203(1):35-45. doi: 10.1007/s00430-013-0312-3. Epub 2013 Sep 22.
6
Rare and emerging viral infections in transplant recipients.移植受者中的罕见和新兴病毒感染。
Clin Infect Dis. 2013 Oct;57(8):1182-8. doi: 10.1093/cid/cit456. Epub 2013 Jul 9.
7
Emerging viral diseases in kidney transplant recipients.肾移植受者新发病毒病。
Rev Med Virol. 2013 Jan;23(1):50-69. doi: 10.1002/rmv.1732. Epub 2012 Nov 7.